EuroBiotech: More Articles of Note

newspapers
(Pixabay)

> Lundbeck terminated development of Lu AF35700 in the wake of the failure of the drug in patients with schizophrenia. Release 

> Analysts at Jefferies raised their price target for Genmab after reviewing the prospects of its pipeline programs. Genmab reported first-half results this week. Statement 

> The Dementia Discovery Fund invested £6.5 million ($7.9 million) in AstronauTx, a startup that aims to treat Alzheimer’s disease by targeting astrocytes. Release 

Submissions Open

Fierce Innovation Awards: Life Sciences Edition 2020

Submit your entry to demonstrate innovative technologies and services that have the potential to make the greatest impact for biotech and pharma companies.

> AC Immune entered into a neurodegenerative disease research collaboration with the University of Pennsylvania. Statement 

> Scotland’s Synpromics accepted a takeover offer from AskBio. Release 

Suggested Articles

A delay to Moderna's phase 3 COVID-19 study is part of a trend of tensions in the biotech’s relationship with the U.S. government, Reuters reported.

GlaxoSmithKline is continuing its strategy of giving out access to its vaccine platform as it adds Medicago to its growing partners list.

Annexon Biosciences and AlloVir are seeking a $100 million IPO apiece in a buoyant market that shows no signs of slowing down.